Efficacy and safety of a modified Vaccinia Ankara-NP+M1 vaccine combined with QIV in people aged 65 and older: a randomised controlled clinical trial (INVICTUS)

Efficacy and safety of a modified Vaccinia Ankara-NP+M1 vaccine combined with QIV in people aged 65 and older: a randomised controlled clinical trial (INVICTUS)

<br><strong>Background: </strong>Pre-existing T cell responses to influenza have been correlated with improved clinical outcomes in natural history and human challenge studies. We aimed to determine the efficacy, safety and immunogenicity of a T-cell directed vaccine in older peopl...

Full description

Bibliographic Details
Main Authors: Butler, C, Ellis, C, Folegatti, P, Swayze, H, Allen, J, Lawrie, A, Yu, L, Shanyinde, M, Bellamy, D, Mair, C, Flaxman, A, Ewer, KJ, Gilbert, S
Other Authors: INVICTUS Investigators
Format: Journal article
Language:English
Published: MDPI 2021

Similar Items

Similar Items